Skip to content
AWK$142.08-0.67(-0.47%)American Water Contributes Expertise at California Water Association 2026 Summit American Water (NYSE: AWK), the largest regulated water and wastewater utility company in the U.S., will join important conversations and contribute...[9:03:00 AM ET]TFC$48.91+0.47(+0.97%)Truist names Alex Bartlett regional president for Greater Washington and Maryland Truist Financial Corporation (NYSE: TFC) today announced Alex Bartlett has been named regional president for Greater Washington and Maryland. A...[9:03:00 AM ET]MKTW$19.58+0.75(+3.98%)MarketWise, Inc. Declares Quarterly Dividend on Class A Common Stock of $0.45 Per Share[9:00:14 AM ET]UFPI$80.93-0.30(-0.37%)UFP Packaging Expands Gulf Coast Pallet Network with Acquisition of Apache Products UFP Packaging, a division of UFP Industries (Nasdaq: UFPI), announced this week the acquisition of Apache Products, Inc., a pallet producer based in...[9:00:00 AM ET]THFF$77.70+1.24(+1.62%)First Financial Corporation Reports Third Quarter Results[9:00:00 AM ET]FTNT$181.84-1.49(-0.81%)Fortinet Expands Unified SASE to Simplify Microbranch Security[9:00:00 AM ET]VELO$6.61+0.12(+1.85%)Velo3D to Announce Third Quarter 2026 Results on November 10, 2026 Velo3D, Inc. (Nasdaq: VELO), a leading metal additive manufacturing technology company, today announced that it will release its third quarter 2026...[9:00:00 AM ET]CPB$20.53-0.10(-0.48%)Campbell's® Marks Five Years of Sides Season™ with Its Annual State of the Sides Report Campbell's officially kicked off Sides Season™ with the release of its 2026 State of the Sides Report. Now in its fifth year, the report offers a...[9:00:00 AM ET]TENB$47.55-0.66(-1.37%)Tenable Selected by Atos to Power Continuous Threat Exposure Management Program[9:00:00 AM ET]PLUR$1.23+0.11(+9.82%)Pluri to Host Investor Conference Calls to Discuss Updates and Strategic Developments[9:00:00 AM ET]ATYR$0.12-0.03(-18.77%)aTyr Pharma Announces One-for-40 Reverse Stock Split[9:00:00 AM ET]KD$14.70+0.02(+0.14%)Kyndryl Opens New Cyber Defense Operations Center in Paris Kyndryl (NYSE: KD), a leading provider of mission-critical enterprise technology services, today unveiled a new Cyber Defense Operations Center in...[9:00:00 AM ET]DVN$51.27-0.37(-0.72%)NEQ Operating Strengthens Leadership Team to Support Next Phase of Growth[9:00:00 AM ET]

OPRX · NASDAQ

OptimizeRx Corporation

$8.99 -0.06 (-0.66%)

Company overview

OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers, and patients. The company's products and applications include financial messaging and a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patient support through their EMR and/or e-prescribe systems, as well as brand awareness and therapeutic support messaging services such as brand awareness messages, reminder ads, and therapeutic support and unbranded messages. It also offers brand support services, which focus on educating and working with pharmaceutical manufacturers to identify, formulate, and implement eRx media strategies, including drug file integration, sales force training, and strategy development services for promoting their products.

Sector
Healthcare
Industry
Medical - Healthcare Information Services
Exchange
NASDAQ
Market cap
$169M
Employees
128
Headquarters
Waltham, MI
CEO
Stephen L. Silvestro
Listed
November 28, 2007
P/E
24.54
Dividend yield
0.00%

Company financials

Revenue
$107M
Gross profit
$74.1M
Operating income
$14.6M
EBITDA
$18.8M
Net income
$6.8M
EPS
$0.37
Total assets
$167M
Total debt
$23.7M
Gross margin
69.05%
Net margin
6.37%
Earnings yield
4.08%

Revenue segmentation

By product (FY 2025)
By region (FY 2025)

No geographic segmentation.

Showing FY 2025

Price chart

4.345.707.078.449.80
OPRX 1D NASDAQ O9.02H9.25L8.94C9.05-0.10 (-1.09%)Vol25.80K

News

15-min delaySigned-out view is delayed 15 minutes. Log in on Pro for the live news desk.

Source
Date
Type
Ticker Type Headline Source Published
OPRXOptimizeRx Corporation Press release OptimizeRx and PulsePoint Partner to Connect HCP Media Across the Funnel GlobeNewswire
OPRXOptimizeRx Corporation Stock news Will OPRX's OpenPath Deal Help TTD Capture More Healthcare Ad Dollars? Zacks Investment Research
OPRXOptimizeRx Corporation Press release OptimizeRx Brings Net New Authenticated HCP Reach to The Trade Desk Through OpenPath GlobeNewsWire
OPRXOptimizeRx Corporation Stock news OptimizeRx: Gross Margin Gains And Improved Long-Term Outlook Seeking Alpha
OPRXOptimizeRx Corporation Stock news Reviewing OptimizeRx (NASDAQ:OPRX) & Aclarion (NASDAQ:ACON) Defense World
OPRXOptimizeRx Corporation Press release OptimizeRx Expands Natural Language Audience Builder to Unify HCP and DTC Audience Intelligence GlobeNewsWire
OPRXOptimizeRx Corporation Press release OptimizeRx to Participate in the 10th Annual Lake Street Best Ideas Growth Conference GlobeNewswire
OPRXOptimizeRx Corporation Press release OptimizeRx Appoints Pharma Commercialization and AI Expert Troy Sarich as Company Advisor GlobeNewsWire
OPRXOptimizeRx Corporation Stock news OptimizeRx Q2 Earnings Call Highlights MarketBeat
OPRXOptimizeRx Corporation Stock news OptimizeRx Corporation (OPRX) Q2 2026 Earnings Call Transcript Seeking Alpha
OPRXOptimizeRx Corporation Stock news OptimizeRx Corp. (OPRX) Q2 Earnings and Revenues Top Estimates Zacks Investment Research
OPRXOptimizeRx Corporation Press release OptimizeRx Announces Finance Leadership Appointments to Support the Next Phase of Growth GlobeNewsWire
OPRXOptimizeRx Corporation Press release OptimizeRx Reports Second Quarter 2026 Financial Results and Updates Fiscal Year 2026 Guidance GlobeNewsWire
OPRXOptimizeRx Corporation Press release OptimizeRx Appoints Veteran Point of Care Marketing Leader Sarah Bast as Chief Marketing Officer GlobeNewsWire
OPRXOptimizeRx Corporation Press release OptimizeRx to Participate in Upcoming Investor Conferences GlobeNewsWire
OPRXOptimizeRx Corporation Stock news OptimizeRx vs. Doximity: Which Digital Health Stock Is the Better Bet? Zacks Investment Research
OPRXOptimizeRx Corporation Stock news OptimizeRx Stock Down 30% in a Month: Should Investors Hold or Fold? Zacks Investment Research
OPRXOptimizeRx Corporation Stock news OPRX Boosts DSP Revenue Potential While Navigating Near-Term Headwinds Zacks Investment Research
OPRXOptimizeRx Corporation Stock news OptimizeRx Cuts Revenue Outlook: Will Pressures Ease Ahead? Zacks Investment Research
OPRXOptimizeRx Corporation Stock news OptimizeRx Q1 Earnings Call Highlights MarketBeat
FAQ

Questions about OptimizeRx Corporation

What does OptimizeRx Corporation do?
OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers, and patients. The company's products and applications include financial messaging and a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patient support through their EMR and/or e-prescribe systems, as well as brand awareness and therapeutic support messaging services such as brand awareness messages, reminder ads, and therapeutic support and unbranded messages. It also offers brand support services, which focus on educating and working with pharmaceutical manufacturers to identify, formulate, and implement eRx media strategies, including drug file integration, sales force training, and strategy development services for promoting their products.
What is OPRX's market cap?
OptimizeRx Corporation (OPRX) is a listed stock with a live quote. The latest market cap on this page is $169M.
Where is OptimizeRx Corporation headquartered?
OptimizeRx Corporation is headquartered in Waltham, MI.
How do I get OPRX news from the API?
Call GET /v1/news?tickers=OPRX. Add type=news, type=press_release, or type=legal to take one feed. Pro keys search the full archive in real time. Free keys are delayed 15 minutes and return the last year. Signed-out visitors and Free accounts see that same year on this page. Pro sees the full archive.
How far back does OPRX news go?
Signed-out visitors and Free accounts see the last year of stock news, press releases, and legal notices for OPRX, 15 minutes behind, and each headline links to the publisher. Pro, including the 7-day trial, sees the full archive as headlines are ingested. A Free API key returns the last year. Pro keys search the full archive.
Is the OPRX price on this page from the API?
The price and daily change update during the US session for every visitor. That quote is context on this page. It is not part of the news API. The chart is one candle per session from the start of 2020. 1W, 1M, and 1Y group those sessions.
Can I use the Pro plan commercially?
No. The Pro plan cannot be used for commercial work. A product you sell, work you do for a client, or redistribution of the feed needs a custom plan and a license. Email [email protected].

Real-time stock news for $15 a month.

Start a 7-day Pro trial. A card is required. REST, WebSocket, and MCP are included, with 1,000 REST requests a day. You won't be charged during the trial. Unless you cancel, the card is billed for Pro when it ends.